Tranexamic Technologies

About

Tranexamic Technologies designates a group of affiliated companies managed by two medical industry entrepreneurs with deep experience in new product identification and development. We have assembled a team of experts from academia, clinical practice, private labs, and professional organizations to develop very broad new therapies based on the intersection of certain fundamental biological activities and previously unexamined mechanisms of action of a new class of drugs that we have named the Tranexamic Class Antagonists (TXCAs) of positively charged amino acids.